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301 Our adaptive means to encourage treatment adherence in
CF patients
A. Teleshov1, L. Bentur1, J. Rivlin2, M. Salameh1,2. 1Meyer-Children’s Hospital
of Haifa, Rambam-Health Care Campus, Pediatric Pulmonary Division, Haifa,
Israel; 2Lady Davis Carmel Medical Center, CF Center, Haifa, Israel
Objective: The aim of the project is to increase adherence to treatment, and as a
result to improve CF patients’ quality of life. Our secondary aim is to offer patients
the opportunity to choose the easier and most appropriate way to treat themselves.
Introduction: Studies indicate that CF patients have poor adherence to treatment.
This could be accompanied by serious respiratory exacerbations, decline of pul-
monary function, and increased hospitalization rate. “CF my way” is a program
developed by Quittner consisting of four steps: questionnaire, identifying barrier(s)
to treatment adherence, choosing the most appropriate solution by the patient, tele-
phone supervision after one week. CF patients in northern Israel come from diverse
ethnicities: Arabic and Jewish (Muslim, Christian, Druze, Sephardic, Ashkenazi,
new immigrants). Therefore, any educational program should be modiﬁed to meet
cultural differences.
Methods: 66 CF patients from two medical centers in northern Israel were enrolled
during one year. Six patients refused to participate, 60 patients continued in the
project. Thirty-six were Arabic patients, 24 Jewish patients, one-third were females.
Age range was 7−44 years; median 20 years.
Conclusions: Cultural differences were observed and required modiﬁcation of the
original program. Following modiﬁcation, implementation was associated with im-
proved adherence to treatment regimen: ﬁlling the prescriptions every month, doing
physiotherapy sessions, not missing clinic visits. In addition, there was improvement
in staff–patient communication. Adolescent patients were more involved in their
treatment compared to the beginning of the project.
302 How to manage your in-home antibiotic therapy?
F. Delacollette1, J.P. Sacre2. 1CHR Citadelle, Pediatrics, Liege, Belgium; 2CHR
Citadelle, Liege, Belgium
Objectives: Regular use of intravenous antibiotics (IVAB) requires long periods
of hospitalisation which are disruptive and stressful. Home therapy (HT) has been
developed to improve the quality of life for patients and families. In 2005, we
introduced a system of IVAB HT. An educational booklet has been made to help
patients and/or relatives at home.
Methods: 46 patients (3−64 y) received 314 courses of IVAB (266 HT and 48
in hospital). Strict criteria (compliance and suitable areas at home) needed to
be fullﬁlled by the patient before HT. The CF nurse provides verbal and written
information about all aspects of HT and the patient is allowed to go home when
the nurse considers the patient is capable of carrying out the treatment. They can
call the CF nurse 24 hours a day; CF nurse visits them 1 or 2 times per week.
Results:
– 6 out of 46 patients were excluded by the CF staff from the HT program because
of psychosocial problems (1 family rejected the idea of HT because of stress
and 5 patients were unable to start HT because of unsuitable housing conditions/
psychosocial difﬁculties).
– 40 patients received speciﬁc home care training: 36 were recognized able to HT.
Only 4 of them needed the daily help of a home team nurse.
– Among 266 HT, only 3 courses needed a hospital readmission: 1 for allergy and
2 because of persistent fever.
Conclusions: IVAB HT is an attractive alternative to hospital treatment for many
patients (87% in our experience). Careful patient selection and speciﬁc training help
to ensure safety. Information should be clear and concise, through visual methods
that improve communication with patient and family.
303 Treatment and treatment success in children with a ﬁrst
Pseudomonas infection
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Introduction: Pseudomonas aeruginosa (PsA) infection is a leading cause of
morbidity and mortality in persons with CF. Eradicating this infection in the initial
stage can delay chronic infection. There are 52 children, 0−18 years, under full
CF care at Starship Children’s Health, NZ. Our aim was to determine the number
of 1st PsA infections, the success of eradication, and whether the current Starship
CF recommendations were followed regarding treatment.
Methods: All 1st infections with PsA from respiratory cultures between 01/01/2005
to 31/12/2011 were recorded documenting treatment, eradication and any subse-
quent culture which, if greater than 3 months was deemed a new infection. Our
current recommendation is 2 weeks of intravenous antipseudomonal treatment with
2 antibiotics followed by 3 months of nebulized aminoglycoside.
Results: 26 children had an initial PsA infection at a mean age of 4.8 years (range
2 months to 15 years, 15 males), cultured from cough suction 15, sputum 9 and
BAL 2. Four were treated with iv antibiotics followed by oral ciproﬂoxacin and
3 months nebulizers, 15 were treated with iv antibiotics followed by nebulizers,
6 were treated with oral ciproﬂoxacin and nebulizers. One had atypical pseudomonas
and was not treated. Two did not eradicate PsA, 13 had a second infection at a mean
of 15.9 months (range 4−36 months), and 10 have not regrown to date at mean of
23.4 months (range 2−61 months).
Conclusions: While 92% did not grow Pseudomonas at the end of treatment,
40% remain PsA free after a mean of 14.7 months. 60% were treated according to
protocol. 53.3% treated according to protocol regrew PsA compared to 70% treated
not following protocol.
304 What are the experiences of cystic ﬁbrosis nurses who use
social networking sites (SNS) and receive ‘friend requests’ from
patients: a qualitative study
C. Hayward1, J.W. Albarran2. 1Bristol Royal Inﬁrmary, Respiratory Department,
Bristol, United Kingdom; 2University of the West of England, Faculty of Health
and Life Sciences, Bristol, United Kingdom
Social Networking sites are becoming a part of daily life for millions including
patients living with chronic health needs like cystic ﬁbrosis (CF). Anecdotal
evidence suggests patients use them to contact specialist teams that provide care.
However there is little professional guidance or research currently available.
Methods: The study adopted an exploratory qualitative design with semistructured
electronic email interviews. Participants were approached and recruited via email
from a membership database of the CF nurses association. A total of six nurses
agreed to participate. Data collection involved emailing participants an interview
guide to discuss their experiences and share their perspectives. Where appropriate,
clariﬁcation was sought. Analysis involved open coding, grouping and reduction of
the transcript to identify themes and sub themes that capture the experiences and
perspectives of the participants.
Findings: Surprisingly individuals making a request were often the parents of
patients. Participants recognised the challenges associated with friend requests and
reasons for declining were based on professional distancing and the direct impact
on patient care due to blurred boundaries. The other stance was to embrace the use
of these sites to improve communication between patients and staff, a minority used
these to provide support to patients out of hours and more commonly to remind
about clinic appointments.
Conclusion: This study revealed that SNS are used by patients, their relatives and
staff, and some ﬁnd these a useful addition to the other methods of communication
available. However, clear guidance needs to be available to protect both patients
and staff.
